Europe Advanced Infusion Systems Market By Application (Clinical Nutrition, Chemotherapy, Pain Management, Diabetes, Asthma), By Product (Disposable Infusion System, Elastomeric Infusion System, Ambulatory Infusion System, Volumetric Infusion System, Patient Controlled Analgesia Pump, Syringe Infusion System, Implantable Infusion System), By End-User (Diagnostic Centers, Hospitals, Ambulatory Surgical Centers) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

Europe Advanced Infusion Systems Market By Application (Clinical Nutrition, Chemotherapy, Pain Management, Diabetes, Asthma), By Product (Disposable Infusion System, Elastomeric Infusion System, Ambulatory Infusion System, Volumetric Infusion System, Patient Controlled Analgesia Pump, Syringe Infusion System, Implantable Infusion System), By End-User (Diagnostic Centers, Hospitals, Ambulatory Surgical Centers) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

ID: 1301 | Pages: 145 | November 2016 | Region: Europe


Europe Advanced Infusion Systems Market was worth $XX million in 2016 and estimated to reach $XX million by the end of 2021 with a CAGR of XX%. Infusion systems are medical instruments and disposables, which are used to distribute fluids or administer drugs in the form of solution to the patient’s circulatory system in a precise, controlled and systematic manner. There are various methods to administer a drug into the patient’s system, of which, the most used mode is through intravenous, although arterial, subcutaneous and epidural infusion are more favorable.

Advanced Infusion Systems’ popularity is mainly because of their dependable, ergonomic design and easy-to-use features. These pumps have bolstered their position in a wide range of application areas including diabetes, oncology, enteral feeding pain management, and general infusion. Features like visual monitoring, easy start up, mobility of system, steady and continuous infusion of multiple drugs at the same time, patient safety some of the major factors that are furthering the growth of the potential market of advanced infusion systems over conventional ones. 

Increasing use of infusion products in homecare with encouraging reimbursements has hugely boosted this market. Immensely developed technology in infusion systems which eliminates user-related risks, safety, therapeutic effectiveness, higher bioavailability, increase in healthcare spending are also some other factors that propel the growth of the market. However, to operate these advanced infusion systems, extensive training is required. The presence of strict regulations for product approval and possible medication errors associated with infusion pump may restrain the growth of the market during the forecast period.

Europe advanced infusion systems market is segmented based on type of application, type of product and end-users. Applications are segmented into Clinical Nutrition, Chemotherapy, Pain Management, Diabetes and Asthma Treatment. Product type is segmented into Disposable Infusion System, Elastomeric Infusion System, Ambulatory Infusion System, Volumetric Infusion System, Patient Controlled Analgesia Pump, Syringe Infusion System and Implantable Infusion System. End-users has been further segmented as Diagnostic Centers, Hospitals and Ambulatory Surgical Centers. Further, on the basis of geography, the Europe market is analyzed under various regions namely UK, Spain, Italy, Germany and France.  North America commands the largest regional segment of the global advanced infusion systems market. In 2015, North America accounted for the largest share, with 48.7% of the market, followed by Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Hospira, Inc., is a market leader in infusion technologies globally. The major players in these markets are AngioDynamics, Inc., Medtronic, Inc., Terumo Corporation, Johnson & Johnson, CareFusion Corporation, Animas Corporation, Baxter International, Inc., B. Braun Melsungen AG, I-Flow Corporation, and F. Hoffmann-La Roche Ltd.

1.Introduction                        

            1.1 Market Definition            

            1.2 Study Deliverables                       

            1.3 Base Currency, Base Year and Forecast Periods              

            1.4 General Study Assumptions                     

2. Research Methodology                              

            2.1 Introduction                     

            2.2 Research Phases              

                        2.2.1 Secondary Research     

                        2.2.2 Primary Research         

                        2.2.3 Econometric Modelling

                        2.2.4 Expert Validation          

            2.3 Analysis Design                

            2.4 Study Timeline                 

3. Overview                            

            3.1 Executive Summary                     

            3.2 Key Inferences                 

            3.3 Epidemology                    

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC) 

            4.1 Market Drivers                 

            4.2 Market Restraints            

            4.3 Key Challenges                 

            4.4 Current Opportunities in the Market                  

5. Market Segmentation                                

            5.1 Application                       

                        5.1.1 Introduction      

                        5.1.2 Clinical Nutrition           

                        5.1.3 Chemotherapy  

                        5.1.4 Pain Management        

                        5.1.5 Diabetes

                        5.1.6 Asthma  

                        5.1.7  Y-o-Y Growth Analysis, By Application

                        5.1.8  Market Attractiveness Analysis, By Application          

                        5.1.9  Market Share Analysis, By Application

            5.2 Product                 

                        5.2.1 Introduction      

                        5.2.2 Disposable Infusion System      

                        5.2.3 Elastomeric Infusion System     

                        5.2.4 Ambulatory Infusion System    

                        5.2.5 Volumetric Infusion System      

                        5.2.6 Patient Controlled Analgesia Pump      

                        5.2.7 Syringe Infusion System

                        5.2.8 Implantable Infusion System    

                        5.2.9  Y-o-Y Growth Analysis, By Product      

                        5.2.10  Market Attractiveness Analysis, By Product  

                        5.2.11  Market Share Analysis, By Product    

            5.3 End-User              

                        5.3.1 Introduction      

                        5.3.2 Diagnostic Centers        

                        5.3.3 Hospitals

                        5.3.4 Ambulatory Surgical Centers    

                        5.3.5  Y-o-Y Growth Analysis, By End-User    

                        5.3.6  Market Attractiveness Analysis, By End-User  

                        5.3.7  Market Share Analysis, By End-User    

6. Geographical Analysis                                

            6.1 Introduction                     

                        6.1.1 Regional Trends

                        6.1.2 Impact Analysis 

                        6.1.3 Y-o-Y Growth Analysis  

                                    6.1.3.1 By Geographical Area

                                    6.1.3.2 By Application

                                    6.1.3.3 By Product

                                    6.1.3.4 By End-User

                        6.1.4  Market Attractiveness Analysis

                                    6.1.3.1 By Geographical Area

                                    6.1.3.2 By Application

                                    6.1.3.3 By Product

                                    6.1.3.4 By End-User

                        6.1.5  Market Share Analysis 

                                    6.1.3.1 By Geographical Area

                                    6.1.3.2 By Application

                                    6.1.3.3 By Product

                                    6.1.3.4 By End-User

            6.2 U.K            

            6.3 Spain                    

            6.4 Germany              

            6.5 Italy                      

            6.6 France                  

7.Strategic Analysis                            

            7.1 PESTLE analysis                

                        7.1.1 Political 

                        7.1.2 Economic          

                        7.1.3 Social     

                        7.1.4 Technological    

                        7.1.5 Legal     

                        7.1.6 Environmental  

            7.2 Porter’s Five analysis                   

                        7.2.1 Bargaining Power of Suppliers  

                        7.2.2 Bargaining Power of Consumers          

                        7.2.3 Threat of New Entrants

                        7.2.4 Threat of Substitute Products and Services     

                        7.2.5 Competitive Rivalry within the Industry           

8.Market Leaders' Analysis 

            8.1 Hospira, Inc.                     

                        8.1.1 Overview           

                        8.1.2 Product Analysis

                        8.1.3 Financial analysis          

                        8.1.4 Recent Developments   

                        8.1.5 SWOT analysis  

                        8.1.6 Analyst View     

            8.2 AngioDynamics, Inc.                    

            8.3 Medtronic, Inc.                

            8.4 Terumo Corporation                    

            8.5 Johnson & Johnson                      

            8.6 CareFusion Corporation               

            8.7 Animas Corporation                     

            8.8 Baxter International Inc.              

            8.9 B. Braun Melsungen AG               

            8.10 I-Flow Corporation                     

            8.11 F. Hoffmann-La Roche Ltd                     

9.Competitive Landscape                              

            9.1 Market share analysis                  

            9.2 Merger and Acquisition Analysis             

            9.3 Agreements, collaborations and Joint Ventures             

            9.4 New Product Launches                

10.Market Outlook and Investment Opportunities                           

Appendix                                

            a) List of Tables                      

            b) List of Figures                     

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Europe Advanced Infusion Systems Market By Application, From 2016-2021 (USD Million)
  2. Europe Clinical Nutrition Market By Region, From 2016-2021 (USD Million)
  3. Europe Chemotherapy Market By Region, From 2016-2021 (USD Million)
  4. Europe Pain Management Market By Region, From 2016-2021 (USD Million)
  5. Europe Diabetes Market By Region, From 2016-2021 (USD Million)
  6. Europe Asthma Market By Region, From 2016-2021 (USD Million)
  7. Europe Advanced Infusion Systems Market By Product, From 2016-2021 (USD Million)
  8. Europe Disposable Infusion System Market By Region, From 2016-2021 (USD Million)
  9. Europe Elastomeric Infusion System Market By Region, From 2016-2021 (USD Million)
  10. Europe Ambulatory Infusion System Market By Region, From 2016-2021 (USD Million)
  11. Europe Volumetric Infusion System Market By Region, From 2016-2021 (USD Million)
  12. Europe Patient Controlled Analgesia Pump Market By Region, From 2016-2021 (USD Million)
  13. Europe Syringe Infusion System Market By Region, From 2016-2021 (USD Million)
  14. Europe Implantable Infusion System Market By Region, From 2016-2021 (USD Million)
  15. Europe Advanced Infusion Systems Market By End users, From 2016-2021 (USD Million)
  16. Europe Diagnostic Centers Market By Region, From 2016-2021 (USD Million)
  17. Europe Hospitals Market By Region, From 2016-2021 (USD Million)
  18. Europe Ambulatory Surgical Centers Market By Region, From 2016-2021 (USD Million)
  19. U.K. Advanced Infusion Systems Market By Application, From 2016-2021 (USD Million)
  20. U.K. Advanced Infusion Systems Market By Product, From 2016-2021 (USD Million)
  21. U.K. Advanced Infusion Systems Market By End users, From 2016-2021 (USD Million)
  22. Germany Advanced Infusion Systems Market By Application, From 2016-2021 (USD Million)
  23. Germany Advanced Infusion Systems Market By Product, From 2016-2021 (USD Million)
  24. Germany Advanced Infusion Systems Market By End users, From 2016-2021 (USD Million)
  25. France Advanced Infusion Systems Market By Application, From 2016-2021 (USD Million)
  26. France Advanced Infusion Systems Market By Product, From 2016-2021 (USD Million)
  27. France Advanced Infusion Systems Market By End users, From 2016-2021 (USD Million)
  28. Italy Advanced Infusion Systems Market By Application, From 2016-2021 (USD Million)
  29. Italy Advanced Infusion Systems Market By Product, From 2016-2021 (USD Million)
  30. Italy Advanced Infusion Systems Market By End users, From 2016-2021 (USD Million)
  31. Spain Advanced Infusion Systems Market By Application, From 2016-2021 (USD Million)
  32. Spain Advanced Infusion Systems Market By Product, From 2016-2021 (USD Million)
  33. Spain Advanced Infusion Systems Market By End users, From 2016-2021 (USD Million)
Middle East And Africa Cardiac Marker Testing Market By Type (Troponin I & T, CK-MB, Myoglobin, BNP, HsCRP), Product (Reagent, Instrument (Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA)), Diseas...
Latin America Cardiac Marker Testing Market By Type (Troponin I & T, CK-MB, Myoglobin, BNP, HsCRP), Product (Reagent, Instrument (Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA)), Disease (Acute ...
Asia Pacific Cardiac Marker Testing Market By Type (Troponin I & T, CK-MB, Myoglobin, BNP, HsCRP), Product (Reagent, Instrument (Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA)), Disease (Acute C...
Europe Cardiac Marker Testing Market By Type (Troponin I & T, CK-MB, Myoglobin, BNP, HsCRP), Product (Reagent, Instrument (Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA)), Disease (Acute Coronar...
North America Cardiac Marker Testing Market By Type (Troponin I & T, CK-MB, Myoglobin, BNP, HsCRP), Product (Reagent, Instrument (Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA)), Disease (Acute ...
Cardiac Marker Testing Market By Type (Troponin I & T, CK-MB, Myoglobin, BNP, HsCRP), Product (Reagent, Instrument (Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA)), Disease (Acute Coronary Syndr...
Middle East And Africa Extracorporeal Membrane Oxygenation Machine Market By Modality (Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous (AV)), Application (Respiratory, Cardiac, Extracorporeal Cardiopulmonary Re...
Latin America Extracorporeal Membrane Oxygenation Machine Market By Modality (Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous (AV)), Application (Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitati...
Asia Pacific Extracorporeal Membrane Oxygenation Machine Market By Modality (Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous (AV)), Application (Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitatio...
Europe Extracorporeal Membrane Oxygenation Machine Market By Modality (Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous (AV)), Application (Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation (ECP...
North America Extracorporeal Membrane Oxygenation Machine Market By Modality (Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous (AV)), Application (Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitati...
Extracorporeal Membrane Oxygenation Machine Market By Modality (Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous (AV)), Application (Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation (ECPR)), An...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.